CSIMarket
 


Biotricity Inc   (BTCY)
Other Ticker:  
 
 

BTCY's Capital Expenditures Growth by Quarter and Year

Biotricity Inc 's Capital Expenditures results by quarter and year




BTCY Capital Expenditures (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter March - 0.00 0.03 0.00
III Quarter December 0.00 0.00 0.00 0.00
II Quarter September 0.00 0.00 0.00 0.00
I Quarter June 0.00 0.00 0.00 0.00
FY   0.00 0.00 0.03 0.00



BTCY Capital Expenditures third quarter 2024 Y/Y Growth Comment
Biotricity Inc in the third quarter 2024 recorded Capital Expenditures of $ 0.00 millions.

According to the results reported in the third quarter 2024, Biotricity Inc achieved the best Capital Expenditures growth in Medical Equipment & Supplies industry. While Biotricity Inc ' s Capital Expenditures no change of % ranks overall at the positon no. in the third quarter 2024.




BTCY Capital Expenditures ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter March - - - -
III Quarter December - - - -
II Quarter September - - - -
I Quarter June - - - -
FY   - - - -

Financial Statements
Biotricity Inc 's third quarter 2024 Capital Expenditures $ 0.00 millions BTCY's Income Statement
Biotricity Inc 's third quarter 2023 Capital Expenditures $ 0.00 millions Quarterly BTCY's Income Statement
New: More BTCY's historic Capital Expenditures Growth >>


BTCY Capital Expenditures (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter March - - - -
III Quarter December - - - -
II Quarter September - - - -
I Quarter June - - - -
FY (Year on Year)   - - - -




Capital Expenditures third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Capital Expenditures third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Capital Expenditures by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Biotricity Inc 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BTCY's III. Quarter Q/Q Capital Expenditures Comment


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BTCY's III. Quarter Q/Q Capital Expenditures Comment


Biotricity Inc 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Capital Expenditures 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Capital Expenditures Growth (TTM) - - - - -
Year on Year Capital Expenditures Growth Overall Ranking # # # # #
Seqeuential Capital Expenditures Change (TTM) - - - - -
Seq. Capital Expenditures Growth (TTM) Overall Ranking # # # # #




Cumulative Capital Expenditures growth Comment
In the Dec 31 2023 period, Biotricity Inc 's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Biotricity Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Capital Expenditures growth Comment
In the Dec 31 2023 period, Biotricity Inc 's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Biotricity Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Capital Expenditures Growth
Medical Equipment & Supplies Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
BTCY's Capital Expenditures Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for BTCY's Competitors
Capital Expenditures Growth for Biotricity Inc 's Suppliers
Capital Expenditures Growth for BTCY's Customers

You may also want to know
BTCY's Annual Growth Rates BTCY's Profitability Ratios BTCY's Asset Turnover Ratio BTCY's Dividend Growth
BTCY's Roe BTCY's Valuation Ratios BTCY's Financial Strength Ratios BTCY's Dividend Payout Ratio
BTCY's Roa BTCY's Inventory Turnover Ratio BTCY's Growth Rates BTCY's Dividend Comparisons



Companies with similar Capital Expenditures no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Dec 31 2023
Sunshine Biopharma Inc -0.43%$ -0.431 millions
Infusystem Holdings Inc-0.73%$ -0.730 millions
Stereotaxis Inc -0.81%$ -0.813 millions
Icon Plc-1.03%$ -1.033 millions
Mdxhealth Sa-1.51%$ -1.506 millions
Alpine Immune Sciences Inc -1.72%$ -1.724 millions
Argenx se-2.99%$ -2.987 millions
Abbvie Inc -3.76%$ -3.756 millions
Vanda Pharmaceuticals Inc -3.80%$ -3.802 millions
Warby Parker Inc -4.52%$ -4.516 millions
Bristol myers Squibb Company-4.62%$ -4.624 millions
Baxter International Inc -5.00%$ -5.000 millions
Progyny Inc -5.55%$ -5.548 millions
Precipio inc -5.77%$ -5.769 millions
Koru Medical Systems Inc -6.92%$ -6.916 millions
Ufp Technologies Inc -7.02%$ -7.018 millions
Bio rad Laboratories Inc -7.27%$ -7.272 millions
Endo International Plc-8.13%$ -8.130 millions
Eterna Therapeutics Inc -9.52%$ -9.524 millions
Sotera Health Company-9.63%$ -9.633 millions
Hutchmed china Limited-11.05%$ -11.052 millions
Biolinerx Ltd -11.45%$ -11.450 millions
Petvivo Holdings Inc-11.46%$ -11.461 millions
Novartis Ag-11.52%$ -11.519 millions
Charles River Laboratories International inc -12.02%$ -12.020 millions
Surgery Partners Inc -12.78%$ -12.775 millions
Xbiotech Inc -12.88%$ -12.879 millions
Cardiol Therapeutics inc -13.92%$ -13.917 millions
Merck and Co Inc -13.93%$ -13.925 millions
Conmed Corporation-14.46%$ -14.464 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com